Dear AuntMinnie Member,
In a year of twists and turns in the medical imaging industry, our readers clearly want to keep a close eye on what's going on with the top radiology vendors. It's no surprise, then, that our story by Signify Research analyst Stephen Holloway topped the list of most-read articles on AuntMinnie.com this past week.
Mr. Holloway reviews the first-half performance for each of the top vendors -- GE Healthcare, Siemens Healthineers, Canon Medical Systems, and Philips Healthcare -- and projects their strengths and weaknesses going into the home stretch of 2018. It's an article you can't miss, especially as the run-up to RSNA 2018 begins. Click here to give it another read.
DBT spots more breast cancer
Next up was our story on how a single-view digital breast tomosynthesis (DBT) technique detected 34% more cancers than traditional digital mammography in a large clinical study of nearly 15,000 women in Sweden.
Researchers wanted to see if single-view DBT was sufficient for breast screening. While DBT has been turning in positive clinical results, most of the studies have used two-view DBT, which is more time-consuming and results in a higher radiation dose. Click here to learn more about the study.
For another important article in our Women's Imaging Community this week, check out a proposal by the U.S. Food and Drug Administration to update the regulations enforcing the Mammography Quality Standards Act (MQSA). The MQSA has been the foundation of efforts to ensure the quality and safety of breast screening in the U.S., so any change in how it's being enforced is likely to be closely watched.
We also highlighted several breast ultrasound articles this week: one on whether there should be revisions to the BI-RADS 3 ultrasound category covering lesions considered to be "probably benign" and another on whether contrast ultrasound is a good tool for characterizing breast lesions. These stories and more are available in our Women's Imaging Community at women.auntminnie.com.
ASTRO on tap
The 2018 edition of the American Society for Radiation Oncology (ASTRO) meeting starts on Sunday, and we'll be on the scene in San Antonio filing daily reports for our Radiation Oncology Community.
Until then, check out a new story on how patients undergoing radiation therapy shouldn't be concerned about using skin cream for radiation-induced dermatitis (as long as they don't go overboard).
